Co-Diagnostics Announces Collaboration with ReadyGo Diagnostics

What Happened
Co-Diagnostics, Inc. (CODX) filed a Current Report on Form 8‑K (Item 8.01) on September 16, 2026 announcing a collaboration with ReadyGo Diagnostics Ltd. The company issued a press release the same day; that press release is attached to the 8‑K as Exhibit 99.1 and is incorporated by reference.

Key Details

• Filing date: September 16, 2026 (Form 8‑K, Item 8.01 — Other Events).
• Parties: Co-Diagnostics, Inc. and ReadyGo Diagnostics Ltd.
• Press release announcing the collaboration attached as Exhibit 99.1 to the Form 8‑K.
• The Form 8‑K discloses the announcement but does not include additional financial terms or detailed agreement terms in the filing.

Why It Matters
This 8‑K is the company’s official public disclosure that it has entered a collaboration with ReadyGo Diagnostics. Investors should review the attached press release for details on the scope, timing, and any operational implications, since the Form 8‑K itself does not provide financial or contractual specifics.